Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study
Abstract
Background: Proton pump inhibitors (PPIs) are the most effective antacids and are widely used in the treatment of acid-related diseases. However, the impact of PPIs on bone remains controversial. This study aimed to explore the association between PPIs and osteoporosis-related adverse events in the real world.
Materials and methods: Data from the United States Food and Drug Administration Adverse Event Reporting System from the first quarter of 2004 to the third quarter of 2024 were included in this study. Four pharmacovigilance analyses, reporting odds ratio (ROR), proportional reporting ratio (PRR), information component (IC), and Empirical Bayes geometric mean (EBGM) were used to explore the association between PPIs use and osteoporosis-related adverse events. In addition, we used the Bonferroni corrected P values and 95% confidence interval (95%CI). Meanwhile, the situation of different age and gender groups was examined using subgroup analysis. Additionally, evoked times and Weibull distributions were used to analyze the data further.
Results: At the Primary terms level, esomeprazole, omeprazole and pantoprazole were found to have positive adverse event signals. However, at the overall dimension level of Standardized Medical Dictionary for Regulatory Activities (MedDRA) query, only esomeprazole (ROR: 8.83, 95%CI: 8.53-9.13, P < 0.001) and omeprazole (ROR: 1.54, 95%CI: 1.44-1.66, P < 0.001) signals were positive. Based on subgroup stratification, the study showed that…
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.